Background illustration for clinical trials search

Triple Negative Breast Cancer Clinical Trials

Browse 2,256 triple negative breast cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Estradiol Plus Olaparib for Breast Cancer (PHOEBE)

for
Metastatic Breast Cancer
Location: Lebanon NH
Sponsor: Mary D Chamberlin

Sex: Female

Age: 18+

Code: NCT05900895

Phase 1, Recruiting

Evaluation of Non-Invasive Assays for the Detection of Urothelial Cancer

for
Urothelial Cancer, Cancer, Bladder Neoplasms,
Location: Burlington MA
Sponsor: Lahey Clinic

Sex: All

Age: 18+

Code: NCT00872495

Recruiting

A Study of 177Lu-FAP-2286 in Advanced Solid Tumors

for
Solid Tumor
Location: New York NY, Montreal, Chapel Hill NC, Miami FL,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18+

Code: NCT04939610

Phase 1, Phase 2, Recruiting

Prospective Analysis of EnVisio Spatial Intelligence for Soft Tissue Localization and Guided Surgical Excision

for
Tumors, Breast
Location: Winter Garden FL
Sponsor: Elucent Medical

Sex: Female

Age: 18+

Code: NCT06572410

Recruiting

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Antitumor Activity of ALK202 in Participants with Advanced Solid Tumors

for
Advanced Cancer, Advanced Solid Tumor
Location: Fairfax VA, Margate FL
Sponsor: Shanghai Allink Biotherapeutics Co., Ltd.

Sex: All

Age: 18 - 70+

Code: NCT06707610

Phase 1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Talazoparib and Palbociclib, Axitinib, or Crizotinib for the Treatment of Advanced or Metastatic Solid Tumors, TalaCom Trial

for
Advanced Malignant Solid Neoplasm,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT04693468

Phase 1, Recruiting

A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)

for
Melanoma, Lymphoma, Solid Tumor, Classical Hodgkin Lymphoma,
Location: Boston MA, New York NY, Chicago IL, Fargo ND,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 0 - 17

Code: NCT02332668

Phase 1, Phase 2, Recruiting

The Sleep After Breast Cancer (ABC) Study - Examining Sleep Changes and Biomarkers Among Breast Cancer Patients

for
Anatomic Stage I Breast Cancer AJCC v8,
Location: Columbus OH
Sponsor: Ohio State University Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT07341503

Recruiting

Isatuximab, Bela Maf, Pom, and Dex in Relapsed/Refractory Multiple Myeloma

for
Relapsed Cancer, Refractory Multiple Myeloma, Multiple Myeloma
Location: Boston MA
Sponsor: Massachusetts General Hospital

Sex: All

Age: 18+

Code: NCT05922501

Phase 2, Recruiting

Remote Temperature Monitoring of Patients At Risk for Developing Fever

for
Fever, Cancer, Remote Patient Monitoring
Location: Schenectady NY
Sponsor: AION Biosystems

Sex: All

Age: 18+

Code: NCT06752512

Recruiting

Using Induced-Pluripotent Stem Cells to Model Cancer Therapy-Related Adverse Events

for
Hematopoietic and Lymphatic System Neoplasm,
Location: Jacksonville FL
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT06640010

Recruiting

MCW Master Predict (Profile Related Evidence Determining Individualized Cancer Therapy)

for
Cancer
Location: Milwaukee WI
Sponsor: Sameem M. Abedin, MD

Sex: All

Age: 18+

Code: NCT05802069

Recruiting

A Dose Escalation and Expansion Study of GIGA-564 in Participants With Locally Advanced or Metastatic Solid Tumor Malignancies

for
Advanced or Metastatic Solid Tumor Malignancies
Location: Bethesda MD
Sponsor: GigaGen, Inc.

Sex: All

Age: 18+

Code: NCT06258304

Phase 1, Recruiting

Telehealth Intervention for Improving Distress and Financial Toxicity in the Caregivers

for
Hematopoietic and Lymphatic System Neoplasm,
Location: Winston-Salem NC
Sponsor: Wake Forest University Health Sciences

Sex: All

Age: 18+

Code: NCT06709404

Recruiting

Connect for Cancer Prevention Study (Connect)

for
Cancer, General Research Use
Location: Detroit MI, Atlanta GA, Marshfield WI, Minneapolis MN,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 30 - 70

Code: NCT04609072

Recruiting

TRUDI: TDXD+Durva in HER2+/Low IBC

for
Invasive Breast Cancer, Inflammatory Breast Cancer Stage III,
Location: Boston MA, Houston TX
Sponsor: Filipa Lynce, MD

Sex: Female

Age: 18+

Code: NCT05795101

Phase 2, Recruiting

High Dose Re-Irradiation Utilizing Advanced Deformable Image Registration (DIR) and Individualized Organ At Risk (OAR) Dose Calculations With Organ Specific Toxicity Analysis

for
Solid Tumor
Location: Milwaukee WI
Sponsor: Medical College of Wisconsin

Sex: All

Age: 18+

Code: NCT05301101

Recruiting

Correlates of CRCI and Gut Microbiome Dysbiosis; a Pilot Study

for
Cancer
Location: Galveston TX
Sponsor: The University of Texas Medical Branch, Galveston

Sex: All

Age: 18+

Code: NCT06098404

Recruiting

Attribution of Toxicities Due to Radiotherapy and Immuno-Biological Therapies

for
Cancer, Radiotherapy Side Effect
Location: Montreal
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)

Sex: All

Age: 18+

Code: NCT04115267

Recruiting

IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors

for
Advanced Endometrial Carcinoma,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT05039801

Phase 1, Recruiting

What is triple negative breast cancer?

Triple negative breast cancer, or TNBC, is breast cancer whose cells test negative for estrogen receptors, progesterone receptors, and excess HER2 protein, so hormone therapy and HER2 targeted drugs do not work against it. It tends to grow faster and is more common in women who have not gone through menopause, in Black women, and in people with an inherited BRCA1 mutation, so genetic testing is recommended for everyone diagnosed. In US data, five year relative survival is about 92 percent when it is found while localized, 67 percent with regional spread, and 15 percent once it has reached distant organs. Standard treatment for early stage disease is chemotherapy combined with immunotherapy before surgery, followed by more treatment after; metastatic disease is treated with chemotherapy, immunotherapy for PD-L1 positive tumors, and antibody drug conjugates. Other breast cancers are covered on our breast cancer clinical trials page.

Types of triple negative breast cancer clinical trials

Who can participate in triple negative breast cancer clinical trials?

Is triple negative breast cancer hereditary?

Stages of triple negative breast cancer, and why they matter for trials

How to enroll in a triple negative breast cancer clinical trial